Catalent shares are trading lower after the company's facility underwent inspection for Regeneron's EYLEA.
Portfolio Pulse from Benzinga Newsdesk
Catalent's facility, which is involved in the production of Regeneron's EYLEA, has undergone inspection. This has led to a decrease in the company's share price.
June 28, 2023 | 4:18 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Catalent's share price has decreased following an inspection of its facility used for the production of Regeneron's EYLEA.
The inspection of Catalent's facility, which is involved in the production of a product for another company, has led to uncertainty among investors, causing a decrease in the company's share price. This indicates a direct impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100